Fortescue Elizabeth B, Kaushal Rainu, Landrigan Christopher P, McKenna Kathryn J, Clapp Margaret D, Federico Frank, Goldmann Donald A, Bates David W
Department of Medicine, Quality Improvement, and Risk Management, Children's Hospital, Boston, Massachusetts, USA.
Pediatrics. 2003 Apr;111(4 Pt 1):722-9. doi: 10.1542/peds.111.4.722.
OBJECTIVES: Medication errors in pediatric inpatients occur at similar rates as in adults but have 3 times the potential to cause harm. Error prevention strategies in this setting remain largely untested. The objective of this study was to classify the major types of medication errors in pediatric inpatients and to determine which strategies might most effectively prevent them. METHODS: A prospective cohort study was conducted of 1020 patients who were admitted to 2 academic medical centers during a 6-week period in April and May 1999. Medication errors were characterized by subtype. Physician raters evaluated error prevention strategies and identified those that might be most effective in preventing errors. RESULTS: Of 10 778 medication orders reviewed, 616 contained errors. Of these, 120 (19.5%) were classified as potentially harmful, including 115 potential adverse drug events (18.7%) and 5 preventable adverse drug events (0.8%). Most errors occurred at the ordering stage (74%) and involved errors in dosing (28%), route (18%), or frequency (9%). Three interventions might have prevented most potentially harmful errors: 1) computerized physician order entry with clinical decision support systems (76%); 2) ward-based clinical pharmacists (81%); and 3) improved communication among physicians, nurses, and pharmacists (86%). Interrater reliability of error prevention strategy assignment was good (agreement: 0.92; kappa: 0.82). CONCLUSIONS: Of the assessed interventions, computerized physician order entry with clinical decision support systems; ward-based clinical pharmacists; and improved communication among physicians, nurses, and pharmacists had the greatest potential to reduce medication errors in pediatric inpatients. Development, implementation, and assessment of such interventions in the pediatric inpatient setting are needed.
目的:儿科住院患者用药错误的发生率与成人相似,但造成伤害的可能性是成人的3倍。在此环境下的错误预防策略在很大程度上仍未得到检验。本研究的目的是对儿科住院患者用药错误的主要类型进行分类,并确定哪些策略可能最有效地预防这些错误。 方法:对1999年4月和5月为期6周期间入住2家学术医疗中心的1020例患者进行了一项前瞻性队列研究。用药错误按亚型进行特征描述。医生评估者对错误预防策略进行评估,并确定那些可能最有效地预防错误的策略。 结果:在审查的10778份用药医嘱中,616份包含错误。其中,120份(19.5%)被归类为潜在有害错误,包括115起潜在药物不良事件(18.7%)和5起可预防的药物不良事件(0.8%)。大多数错误发生在医嘱开具阶段(74%),涉及剂量(28%)、给药途径(18%)或频次(9%)错误。三种干预措施可能预防大多数潜在有害错误:1)配备临床决策支持系统的计算机化医生医嘱录入(76%);2)病房临床药师(81%);3)改善医生、护士和药师之间的沟通(86%)。错误预防策略分配的评估者间信度良好(一致性:0.92;kappa值:0.82)。 结论:在所评估的干预措施中,配备临床决策支持系统的计算机化医生医嘱录入、病房临床药师以及改善医生、护士和药师之间的沟通在减少儿科住院患者用药错误方面具有最大潜力。需要在儿科住院环境中开发、实施和评估此类干预措施。
Arch Intern Med. 2004-4-12
Jt Comm J Qual Patient Saf. 2007-5
Am J Health Syst Pharm. 2007-5-1
J Qual Clin Pract. 1999-3
J Am Med Inform Assoc. 1999
J Pediatr Pharmacol Ther. 2025-8
Clinicoecon Outcomes Res. 2025-7-22
BMC Pharmacol Toxicol. 2025-5-22
Healthcare (Basel). 2024-10-25
J Pediatr Pharmacol Ther. 2024-4
Pediatr Qual Saf. 2023-7-10